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DNA repair: Getting past a lesion — at a cost
Bryn A. Bridges
Bacteria survive many types of synthesis-blocking DNA
lesion by inducing a number of proteins that enable
their polymerases to synthesize past a lesion, albeit at
the cost of an increased mutation rate. This process has
now been convincingly achieved in vitro, opening the
way to a fuller understanding of the mechanism.
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When bacteria are growing actively and under little stress
in the laboratory, there is minimal need for mutations as a
substrate for selection and evolution. Mutation rates are
kept at a low level — typically around 10–10 per base pair
per generation — by fidelity mechanisms such as base
selection, proof-reading and mismatch correction. In
nature, however, such ideal circumstances are rare.
Growth is usually restricted by the unavailability of nutri-
ents or the presence of inhibitory substances, and so bac-
teria have developed various ways in which their mutation
rate is raised in order to generate the variability that can
increase their chances of survival. Important among these
is an inducible error-prone pathway, commonly known as
SOS mutagenesis. This pathway is typically induced when
DNA damage is detected, and it is responsible for mediat-
ing much, perhaps most, of the mutagenic activity of
chemicals and radiations. Recent work [1] has shown that
SOS mutagenesis is also induced during senescence of
bacterial colonies, another situation where new strategies
for survival are demanded.
Three decades of genetic studies (reviewed in [2]) have
elucidated the proteins that are essential for SOS mutage-
nesis, namely RecA, the single-strand binding protein Ssb,
the RecA-generated UmuD cleavage product UmuD′ and
UmuC. They have also provided strong circumstantial evi-
dence that these proteins allow a complex containing all or
part of DNA polymerase III holoenzyme to catalyse
‘translesion synthesis’ past non-instructional lesions in the
template strand. The actual mechanism of translesion syn-
thesis, however, remains cloaked in mystery. Reconstruc-
tion of SOS mutagenesis in vitro would be a major step in
allowing models to be tested, and this has now been
achieved by two groups [3,4].
The main problem in reconstituting SOS mutagenesis in
vitro has been an inability to purify usable quantities of
active UmuC, because of the protein’s insolubility in
water. An earlier partially successful attempt [5] used a
denatured–renatured form of UmuC, which had relatively
little activity. The problem has now been overcome in two
different ways. Tang et al. [3] were able to purify UmuC
directly as a complex with two molecules of UmuD′
(UmuD′2C). Reuven et al. [4] purified both UmuD′ and
UmuC as soluble proteins fused to a portion of the
maltose binding protein (MBP), which could be released
from UmuD′ but not from UmuC. Fortunately for them,
the MBP-tagged UmuC proved to be biologically active
and could be used in the reconstituted system.
Both groups used a primer–template substrate with an
abasic site in the template as a model DNA lesion. It is
known that polymerase III holoenzyme is almost com-
pletely unable to insert a base opposite the abasic site and
continue synthesis. Addition of RecA, Ssb and UmuD′2C
(or UmuD′ plus MBP-tagged UmuC), together with ATP
and the four deoxynucleotide triphosphates (dNTPs),
allowed translesion synthesis and completion of the
replication product. Absence of any one of RecA, Ssb or
UmuD′2C reduced the extent of translesion synthesis. In
essence, therefore, both groups have achieved a practical
reconstituted system. How then do the results impinge
upon the speculative models of the mechanism of
translesion synthesis that are currently in vogue?
When the first experiments implicating polymerase III
holoenzyme in translesion synthesis were reported [6], an
inducible factor was postulated to enable polymerase III
holoenzyme, when faced with a lesion in the template
strand, to override its normal high specificity and insert a
base opposite the lesion. The base was perhaps chosen at
random, thus leading to base-pair substitution mutations.
Subsequent work confirmed the involvement of poly-
merase III holoenzyme and revealed that the inducible
factors are UmuC, UmuD′ and RecA. Not all translesion
synthesis events are mutagenic, but in those that are, the
process can be divided operationally into two steps: inser-
tion of a base opposite the lesion (misincorporation), and
bypass or elongation from the resulting ‘mismatch’. Indi-
rect genetic evidence points to polymerase III holoen-
zyme as being involved at least in the bypass step, and
UmuC and UmuD′ as being involved in the bypass and
not in the misincorporation step, but proof of this has been
hard to come by. Convincing evidence as to how they
carry out their roles is also lacking.
Reuven et al. [4] found that, in the absence of polymerase
III holoenzyme, the remaining components of the recon-
stituted system carry out translesion synthesis to less than
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0.5% of the extent in the presence of polymerase III
holoenzyme. Tang et al. [3], in contrast, observed signifi-
cant lesion bypass even in the absence of exogenous poly-
merase III holoenzyme. They cannot tell whether their
UmuD′2C has a low polymerase activity or whether an
impurity is present, but the latter seems the most likely
explanation given that Reuven et al. [4] purified their
Umu proteins completely differently and found no poly-
merase activity. It might, of course, be argued that the
MBP tag on the UmuC made by Reuven et al. [4] might
have inactivated polymerase function. Whether or not
UmuC has an intrinsic polymerase activity, it appears to
be inessential for translesion synthesis.
A major conclusion of the paper by Reuven et al. [4] is that
some translesion synthesis can be mediated by poly-
merase III holoenzyme in the absence of UmuD′ and
UmuC, and that when it occurs the polynucleotide chain
is elongated without insertion of any base opposite the
abasic site, leading to a frameshift mutation. They argue
that a major function of the Umu proteins is to convert
potentially lethal frameshift mutations into the milder and
more useful base-pair substitutions. Tang et al. [3] do not
report frameshift mutations and had to use much higher
concentrations of polymerase III holoenzyme to get any
translesion synthesis in the absence of UmuD′2C. Their
substrate is, however, longer than that of Reuven et al. [4],
and examination of their gels suggests that they might not
have had sufficient resolution to detect –1 frameshifts in
the polymerase III holoenzyme lanes. 
Even when polymerase III holoenzyme is acting on
undamaged DNA in vitro it is prone to generate –1
frameshifts to a much greater extent than is observed in
vivo [7]. So it may be that –1 frameshifts produced by
polymerase III holoenzyme during translesion synthesis in
the absence of Umu proteins are indeed real, but are they
biologically relevant? Although most mutations are tar-
geted base substitutions when Umu proteins are present,
it is clear that –1 frameshifts are still produced as a minor-
ity product. This is true, not only in vitro, but also in vivo
when damaged DNA is transformed into SOS-induced
bacteria. This was shown not only by Reuven et al. [4] but
also previously with single-stranded M13 phage contain-
ing a site-directed abasic site [8]. Given that SOS induc-
tion increases the survival of the damaged phage by
promoting translesion synthesis, it is a matter of simple
arithmetic to calculate from the data in these papers
whether SOS-mediated translesion synthesis at abasic
sites results in any change in the number of surviving
phages with frameshift mutations. The bottom line of that
sum is that SOS translesion synthesis, while greatly
increasing the number of viable phages with base substi-
tution mutations, has little or no effect on the number of
viable phages with frameshifts, making it hard to sustain
the contention of Reuven et al. [4] that the role of Umu
proteins is to divert translesion synthesis from a frameshift
to a base-pair substitution pathway.
Do the results so far lead to a better understanding of the
mechanism of SOS mutagenesis? What about the sugges-
tion that Umu proteins cause polymerase III holoenzyme to
override its normally high specificity? Tang et al. [3] found
that, in vitro, polymerase II can function in translesion syn-
thesis in addition to polymerase III holoenzyme. This must
surely make it less likely that Umu proteins interact directly
with the polymerase. UmuD′2C is known to form a
complex with RecA and to bind to single-stranded DNA. It
seems likely that, in doing so, an environment is created in
which either polymerase III holoenzyme or polymerase II
can operate less stringently (see Figure 1). 
Of the two operational steps in translesion synthesis,
everything points to the UmuD′2C complex as being par-
ticularly important in the second, elongation step (bypass).
Whether it does this by encouraging the polymerase, or
whether it has an intrinsic ability to insert a base onto a 3′
mismatch end, acting perhaps as a terminal nucleotidyl
transferase, is still in question. Current models favour the
former, but the alternative has not so far been excluded
and must now surely be amenable to in vitro experimenta-
tion. Genetic studies have suggested that the first step, in
Figure 1
Our current understanding of mutagenic translesion synthesis across,
and beyond, an abasic site in a single-stranded DNA region.
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which nucleotides are inserted opposite damaged bases,
can be carried out without the involvement of Umu pro-
teins. This is confirmed by several in vitro studies in
which dNTP cycling has been demonstrated when a poly-
merase idles opposite a blocking lesion, alternately insert-
ing and then removing nucleotides. It should now be
possible to approach these questions biochemically using
the in vitro system.
Although DNA damage is the best-studied inducer of the
SOS mutagenesis system, and translesion synthesis is the
best-studied consequence, the SOS system can be
induced in other ways, for example in aging colonies [1],
and not all the mutations that are generated arise from
translesion synthesis. Thus, under the influence of
UmuD, UmuC, RecA and Ssb, the DNA polymerase III
complex is not processive and tends to fall off the DNA.
Before doing so, however, it makes insertions at undam-
aged sites [3], an observation consistent with genetic evi-
dence that SOS-induced bacteria are also mutators for
undamaged DNA. These ‘untargeted’ mutations must
contribute to the overall mutagenic effect and support the
view — still a matter of controversy — that the prime
purpose of SOS mutagenesis is the generation of genetic
variability, rather than survival from DNA damage, useful
though this may be to the individual cell. Perhaps the
‘cost’ of getting past a lesion is actually the prime objec-
tive, after all!
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